Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension Study to Evaluate the Long-term Outcomes of Subjects Who Received Treatment for Retinopathy of Prematurity in Study 20090

NCT04015180 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04015180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04015180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension Study to Evaluate the Long-term Outcomes of Subjects Who Received Treatment for Retinopathy of Prematurity in Study 20090
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
March 18, 2020
Completion date
September 19, 2025
Enrollment
100 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy of prematurity (rop)